AKR1C1 inhibitor could enhance the ability of THP to induce apoptosis in bladder cancer cells, improve the anticancer ability of THP, promote tumor cell apoptosis, and reduce drug resistance of tumor cells. This evidence concerns the gene AKR1C1 and urinary bladder carcinoma.